Neurocrine Biosciences, Inc. (NBIX) Revenue History
Neurocrine Biosciences, Inc. (NBIX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $15.00M |
| 2017-12-31 | $161.63M |
| 2018-12-31 | $451.24M |
| 2019-12-31 | $788.10M |
| 2020-12-31 | $1.05B |
| 2021-12-31 | $1.13B |
| 2022-12-31 | $1.49B |
| 2023-12-31 | $1.89B |
| 2024-12-31 | $2.36B |
| 2025-12-31 | $2.86B |
How NBIX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| UTHR | United Therapeutics Corporation | $3.18B |
| QDEL | QuidelOrtho Corp Com | $2.73B |
| NVST | Envista Holdings Corporation | $2.72B |
| PODD | Insulet Corporation | $2.71B |
| BIO | Bio-Rad Laboratories Inc. Class A | $2.58B |
These are five companies in the same sector as NBIX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Neurocrine Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("NBIX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NBIX | $155.94 | -0.42% | 0.17M |
| 3 | ||||
| 4 | ||||
| 5 |